How Does The Use Of Probiotics Affect Gut Health?

Quick answer

Probiotics, particularly strains of Bifidobacterium animalis subsp. lactis, show some evidence of improving digestive comfort and gastrointestinal symptoms in adults without diagnosed GI disorders. Evidence for other gut health benefits across various conditions is limited or uncertain.

🔬 What the research shows

High-quality evidence from randomized controlled trials and systematic reviews indicates that fermented milk containing Bifidobacterium animalis subsp. lactis can improve digestive comfort and reduce digestive symptoms in adults with minor digestive complaints. Meta-analyses and systematic reviews in other populations, such as solid organ transplant recipients and chronic kidney disease patients, show very low certainty evidence and no clear benefits of synbiotics, prebiotics, or probiotics on gut health outcomes. Evidence for probiotic support improving cognitive function in Alzheimer's disease is promising but requires further high-quality studies. In children and adolescents with neuropsychiatric disorders, Bifidobacterium supplementation shows potential but evidence is limited. Gut microbiome-based interventions for obesity in children and adolescents show very low certainty evidence with minimal effects. Probiotic interventions with Lactobacillus in liver transplant patients have not demonstrated clear benefits in preventing infections or complications. Overall, safety profiles are good with minimal adverse events reported. More rigorous, strain-specific, and adequately powered studies are needed to confirm benefits and clarify effective strains and populations.

Best studied probiotic strains

Bifidobacterium animalis subsp. lactis (including CNCM I-2494 and DN-173 010)

High-quality randomized controlled trials (PMID: 19236549, 23480238) show improvement in digestive comfort and reduction in digestive symptoms in adults with minor digestive complaints.

Evidence is strongest for digestive comfort in adults without diagnosed GI disorders; effects in other populations or conditions are less certain.

Lactobacillus (general)

Meta-analysis (PMID: 24599680) in liver transplant patients showed no clear benefit in preventing bacterial sepsis or wound complications; evidence quality very low.

No specific strain identified; benefits uncertain and further research needed.

Bifidobacterium (general)

Systematic reviews (PMID: 33271210, 40528179) suggest potential roles in neuropsychiatric disorders and intestinal barrier function, but evidence is limited or low certainty.

Strain-specific effects not well defined; more research needed.

👥 Who may benefit

Adults with minor digestive discomfort or symptoms Patients with Alzheimer's disease (probiotic-supported intestinal flora balance therapy may improve cognitive function, but evidence is preliminary) Children and adolescents with neuropsychiatric disorders (potential benefit from Bifidobacterium supplementation, but evidence limited) People with obesity aged 0-19 years (prebiotics and synbiotics may have small effects, but evidence is very uncertain)

✅ Safety

Probiotic and synbiotic interventions are generally safe with minimal and mild adverse events reported, such as flatulence, nausea, diarrhea, abdominal pain, and mild digestive discomfort. No serious adverse events related to probiotic use were reported in the reviewed studies.

⚠️ Limitations

Most studies have small sample sizes, short durations, and heterogeneous interventions. Many systematic reviews report very low certainty evidence due to risk of bias, unclear strain identification, and inconsistent outcomes. There is a lack of high-quality, adequately powered randomized controlled trials with standardized probiotic strains and doses. Evidence is often mixed or uncertain, especially in populations with chronic diseases or complex conditions. More research is needed to clarify strain-specific effects and long-term benefits.